U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Infant Acute Lymphoblastic Leukemia

MedGen UID:
889772
•Concept ID:
C4054727
•
Neoplastic Process

Definition

An acute lymphoblastic leukemia that occurs in infancy. [from NCI]

Professional guidelines

PubMed

Recent progress in the treatment of infant acute lymphoblastic leukemia.
Tomizawa D
Pediatr Int 2015 Oct;57(5):811-9. doi: 10.1111/ped.12758. PMID: 26215843
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.
Stumpel DJ, Schneider P, Seslija L, Osaki H, Williams O, Pieters R, Stam RW
Leukemia 2012 Apr;26(4):682-92. Epub 2011 Oct 21 doi: 10.1038/leu.2011.278. PMID: 22015773
Treatment of infant acute lymphoblastic leukemia in Japan. Childhood Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
Nishimura S, Kobayashi M, Ueda K, Ishii E, Okamura J, Kawaha K, Akiyama Y, Imashuku S, Horibe K, Matsuyama T, Shibuya A, Imaizumi M, Tsukimoto I, Nagao T
Int J Hematol 1999 Jun;69(4):244-52. PMID: 10407581

Recent clinical studies

Etiology

Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.
Chen C, Yu W, Alikarami F, Qiu Q, Chen CH, Flournoy J, Gao P, Uzun Y, Fang L, Davenport JW, Hu Y, Zhu Q, Wang K, Libbrecht C, Felmeister A, Rozich I, Ding YY, Hunger SP, Felix CA, Wu H, Brown PA, Guest EM, Barrett DM, Bernt KM, Tan K
Blood 2022 Apr 7;139(14):2198-2211. doi: 10.1182/blood.2021013442. PMID: 34864916Free PMC Article
Infant lymphoblastic leukemia: a single centers 10 year experience.
Yaman-Bajin İ, Aytaç S, Kuşkonmaz B, Uçkan-Çetinkaya D, Ünal Ş, Gümrük F, Çetin M
Turk J Pediatr 2019;61(3):325-329. doi: 10.24953/turkjped.2019.03.002. PMID: 31916708
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG
J Clin Oncol 2019 Sep 1;37(25):2246-2256. Epub 2019 Jul 8 doi: 10.1200/JCO.19.00261. PMID: 31283407
Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM, Stam RW
Curr Opin Pediatr 2017 Feb;29(1):20-26. doi: 10.1097/MOP.0000000000000437. PMID: 27841777
Recent progress in the treatment of infant acute lymphoblastic leukemia.
Tomizawa D
Pediatr Int 2015 Oct;57(5):811-9. doi: 10.1111/ped.12758. PMID: 26215843

Diagnosis

Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy.
Kotecha RS
Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):611-617. doi: 10.1182/hematology.2022000359. PMID: 36485124Free PMC Article
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.
Chen C, Yu W, Alikarami F, Qiu Q, Chen CH, Flournoy J, Gao P, Uzun Y, Fang L, Davenport JW, Hu Y, Zhu Q, Wang K, Libbrecht C, Felmeister A, Rozich I, Ding YY, Hunger SP, Felix CA, Wu H, Brown PA, Guest EM, Barrett DM, Bernt KM, Tan K
Blood 2022 Apr 7;139(14):2198-2211. doi: 10.1182/blood.2021013442. PMID: 34864916Free PMC Article
Infant lymphoblastic leukemia: a single centers 10 year experience.
Yaman-Bajin İ, Aytaç S, Kuşkonmaz B, Uçkan-Çetinkaya D, Ünal Ş, Gümrük F, Çetin M
Turk J Pediatr 2019;61(3):325-329. doi: 10.24953/turkjped.2019.03.002. PMID: 31916708
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Urtishak KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, Porazzi P, Vincent TL, Teachey DT, Tasian SK, Moore JS, Seif AE, Jin S, Barrett JS, Robinson BW, Chen IL, Harvey RC, Carroll MP, Carroll AJ, Heerema NA, Devidas M, Dreyer ZE, Hilden JM, Hunger SP, Willman CL, Borden KLB, Felix CA
Oncogene 2019 Mar;38(13):2241-2262. Epub 2018 Nov 26 doi: 10.1038/s41388-018-0567-7. PMID: 30478448Free PMC Article
Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM, Stam RW
Curr Opin Pediatr 2017 Feb;29(1):20-26. doi: 10.1097/MOP.0000000000000437. PMID: 27841777

Therapy

Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy.
Kotecha RS
Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):611-617. doi: 10.1182/hematology.2022000359. PMID: 36485124Free PMC Article
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.
Chen C, Yu W, Alikarami F, Qiu Q, Chen CH, Flournoy J, Gao P, Uzun Y, Fang L, Davenport JW, Hu Y, Zhu Q, Wang K, Libbrecht C, Felmeister A, Rozich I, Ding YY, Hunger SP, Felix CA, Wu H, Brown PA, Guest EM, Barrett DM, Bernt KM, Tan K
Blood 2022 Apr 7;139(14):2198-2211. doi: 10.1182/blood.2021013442. PMID: 34864916Free PMC Article
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG
J Clin Oncol 2019 Sep 1;37(25):2246-2256. Epub 2019 Jul 8 doi: 10.1200/JCO.19.00261. PMID: 31283407
Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM, Stam RW
Curr Opin Pediatr 2017 Feb;29(1):20-26. doi: 10.1097/MOP.0000000000000437. PMID: 27841777
Infant acute lymphoblastic leukemia: Lessons learned and future directions.
Pieters R
Curr Hematol Malig Rep 2009 Jul;4(3):167-74. doi: 10.1007/s11899-009-0023-4. PMID: 20425430

Prognosis

Infant lymphoblastic leukemia: a single centers 10 year experience.
Yaman-Bajin İ, Aytaç S, Kuşkonmaz B, Uçkan-Çetinkaya D, Ünal Ş, Gümrük F, Çetin M
Turk J Pediatr 2019;61(3):325-329. doi: 10.24953/turkjped.2019.03.002. PMID: 31916708
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG
J Clin Oncol 2019 Sep 1;37(25):2246-2256. Epub 2019 Jul 8 doi: 10.1200/JCO.19.00261. PMID: 31283407
Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM, Stam RW
Curr Opin Pediatr 2017 Feb;29(1):20-26. doi: 10.1097/MOP.0000000000000437. PMID: 27841777
Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
Bueno C, Montes R, Catalina P, Rodríguez R, Menendez P
Leukemia 2011 Mar;25(3):400-10. Epub 2010 Dec 7 doi: 10.1038/leu.2010.284. PMID: 21135858
Infant acute lymphoblastic leukemia: Lessons learned and future directions.
Pieters R
Curr Hematol Malig Rep 2009 Jul;4(3):167-74. doi: 10.1007/s11899-009-0023-4. PMID: 20425430

Clinical prediction guides

Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T, Takagi M, Sato-Otsubo A, Nishimura A, Nagae G, Yamagishi C, Tamura M, Tanaka Y, Asada S, Takeda R, Tsuchiya A, Wang X, Yoshida K, Nannya Y, Ueno H, Akazawa R, Kato I, Mikami T, Watanabe K, Sekiguchi M, Seki M, Kimura S, Hiwatari M, Kato M, Fukuda S, Tatsuno K, Tsutsumi S, Kanai A, Inaba T, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Kotecha RS, Cruickshank MN, Ishikawa F, Morio T, Eguchi M, Deguchi T, Kiyokawa N, Arakawa Y, Koh K, Aoki Y, Ishihara T, Tomizawa D, Miyamura T, Ishii E, Mizutani S, Wilson NK, Göttgens B, Miyano S, Kitamura T, Goyama S, Yokoyama A, Aburatani H, Ogawa S, Takita J
Nat Commun 2022 Aug 30;13(1):4501. doi: 10.1038/s41467-022-32266-4. PMID: 36042201Free PMC Article
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.
Chen C, Yu W, Alikarami F, Qiu Q, Chen CH, Flournoy J, Gao P, Uzun Y, Fang L, Davenport JW, Hu Y, Zhu Q, Wang K, Libbrecht C, Felmeister A, Rozich I, Ding YY, Hunger SP, Felix CA, Wu H, Brown PA, Guest EM, Barrett DM, Bernt KM, Tan K
Blood 2022 Apr 7;139(14):2198-2211. doi: 10.1182/blood.2021013442. PMID: 34864916Free PMC Article
Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
Loftus JP, Yahiaoui A, Brown PA, Niswander LM, Bagashev A, Wang M, Schauf A, Tannheimer S, Tasian SK
Haematologica 2021 Apr 1;106(4):1067-1078. doi: 10.3324/haematol.2019.241729. PMID: 32414848Free PMC Article
Infant lymphoblastic leukemia: a single centers 10 year experience.
Yaman-Bajin İ, Aytaç S, Kuşkonmaz B, Uçkan-Çetinkaya D, Ünal Ş, Gümrük F, Çetin M
Turk J Pediatr 2019;61(3):325-329. doi: 10.24953/turkjped.2019.03.002. PMID: 31916708
Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM, Stam RW
Curr Opin Pediatr 2017 Feb;29(1):20-26. doi: 10.1097/MOP.0000000000000437. PMID: 27841777

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...